Personnel Changes
TOKYO, February 3, 2022 --Chugai Pharmaceutical Co., Ltd.(TOKYO: 4519) announced the following personnel changes, effective March 29 and April 1, 2022 respectively.
[Details of Personnel Changes]
Effective, March 29, 2022
Directors
Name | New Responsibilities | Current Responsibilities |
Osamu Okuda | Representative Director, President | Representative Director, President |
Chief Executive Officer (CEO) | Chief Executive Officer (CEO) | |
Supervisory responsibility for | Supervisory responsibility for | |
Corporate Planning, Partnering, | Clinical Development, | |
External Affairs and Audit | Pharmaceutical Technology, Drug | |
In charge of Corporate Planning | Safety, Medical Affairs, Marketing & | |
Dept., External Affairs Dept., and | Sales and Foundation Medicine | |
Audit Dept. | ||
Hisafumi Yamada | Director, Executive Vice President | Executive Vice President |
Supervisory responsibility for | Supervisory responsibility for | |
Project & Lifecycle Management | Project & Lifecycle Management | |
(R&D), Research, Translational | (R&D), Research and Translational | |
Research, Clinical Development | Research | |
and Pharmaceutical Technology | ||
Toshiaki Itagaki | Director, Executive Vice President | Executive Vice President |
Chief Financial Officer (CFO) | Chief Financial Officer (CFO) | |
Supervisory responsibility for | Supervisory responsibility for | |
Finance & Accounting, Corporate | Finance & Accounting, Corporate | |
Communication and Purchasing | Communication, Purchasing and | |
Head of Finance Supervisory Div. | Digital Transformation | |
Head of Finance Supervisory Div. |
- The appointment of Osamu Okuda as Chairman of the Board of Directors is subject to approval at the Board of Directors Meeting, which is scheduled to be convened on March 29, 2022
- The appointment of Hisafumi Yamada and Toshiaki Itagaki as Directors is subject to approval at the 111th Annual General Meeting of Shareholders, which is scheduled to be convened on March 29, 2022.
- Tatsuro Kosaka is scheduled to retire from Representative Director, Chairman as of March 29, 2022 to be appointed as Senior Advisor.
- Motoo Ueno is scheduled to retire from Representative Director, Deputy Chairman as of March 29, 2022 to be appointed as Senior Advisor.
Executive Officers
Name | New Responsibilities | Current Responsibilities |
Shinya Unno | Deputy President | Deputy President |
Special Mission for CEO | Supervisory responsibility for | |
Human Resources Management, | ||
Legal, Intellectual Property and | ||
General Affairs | ||
In charge of General Affairs Dept. | ||
Tetsuya | Executive Vice President | Executive Vice President |
Yamaguchi | Supervisory responsibility for | Supervisory responsibility for |
Project & Lifecycle Management | Project & Lifecycle Management | |
(Marketing), Drug Safety, Medical | (Marketing), Corporate Planning, | |
Affairs and Foundation Medicine | Quality & Regulatory Compliance | |
Head of Project & Lifecycle | Head of Project & Lifecycle | |
Management Unit | Management Unit | |
In charge of Corporate Planning | ||
Dept. | ||
Junichi Ebihara | Senior Vice President | Senior Vice President |
Supervisory responsibility for Legal, | In charge of Legal Dept. and | |
Intellectual Property, General | Intellectual Property Dept. | |
Affairs, Risk Management, | ||
Compliance, and Quality & | ||
Regulatory Compliance | ||
In charge of Legal Dept., | ||
Intellectual Property Dept., and | ||
General Affairs Dept. | ||
Shinji Hidaka | Vice President | Vice President |
Supervisory responsibility for | Head of Marketing & Sales Div. | |
Marketing & Sales | ||
Head of Marketing & Sales Div. | ||
Yoshiyuki Yano | Vice President | Vice President |
Supervisory responsibility for | Head of Human Resources | |
Human Resource Management and | Management Dept. | |
EHS | ||
Head of Human Resources | ||
Management Dept. | ||
In charge of Sustainability Dept. | ||
Satoko Shisai | Vice President | Vice President |
Supervisory responsibility for Digital | Head of Digital Transformation Unit | |
Transformation | ||
Head of Digital Transformation Unit | ||
2 / 3 |
Effective April 1, 2022
Executive Officers
Name | New Responsibilities | Current Responsibilities |
Shinji Hidaka | Executive Vice President | Vice President |
Supervisory responsibility for | Supervisory responsibility for | |
Marketing & Sales | Marketing & Sales | |
Head of Marketing & Sales Div. | Head of Marketing & Sales Div. | |
Yoshiyuki Yano | Executive Vice President | Vice President |
Supervisory responsibility for | Supervisory responsibility for | |
Human Resource Management and | Human Resource Management and | |
EHS | EHS | |
Head of Human Resources | Head of Human Resources | |
Management Dept. | Management Dept. | |
In charge of Sustainability Dept. | In charge of Sustainability Dept. | |
Satoko Shisai | Executive Vice President | Vice President |
Supervisory responsibility for Digital | Supervisory responsibility for Digital | |
Transformation | Transformation | |
Head of Digital Transformation Unit | Head of Digital Transformation Unit | |
Hitoshi Iikura | Vice President | Head of Research Div. |
Head of Research Div. | ||
Masayoshi | Vice President | Head of Quality & Regulatory |
Higuchi | Head of Quality & Regulatory | Compliance Unit |
Compliance Unit |
- Shinya Unno and Hiroyuki Matsumoto are scheduled to retire from Executive Officers as of March 31, 2022.
###
3 / 3
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Chugai Pharmaceutical Co. Ltd. published this content on 03 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 February 2022 08:08:05 UTC.